Domestic P‑CAB drug 자큐보 shows GERD efficacy and safety in >5,500‑patient real‑world study
Oncogenic Therapeutics reports that 자큐보 (자스타프라잔시트르산염) improved GERD symptoms and was well tolerated in a real‑world study of over 5,500 patients, including those switched from PPIs.